Analysis of glioblastoma-metabolism by MRI-Spectroscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014760

Enrollment

Registered

2019-03-05

Start date

2018-05-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9

Interventions

Group 1: In the study, an MRI spectroscopy (a measurement lasting only a few minutes) is carried out in order to be able to detect any differences in tumor metabolism in the tumor center and periphera

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Intracranial tumors

Exclusion criteria

Exclusion criteria: in need of protection (children)

Design outcomes

Primary

Measure	Time frame
Minimum 10 patients should be examinated with MRS (magnetic resonance spectroscopy). The results of edge and central regions of the tumor will be compared.	—

Secondary

Measure	Time frame
The data-research is to be continued for about three years.	—

Countries

Germany

Contacts

Public ContactCarolin Kubelt

Klinik für Neurochirurgie am UKSH, Campus Kiel

Carolin.Kubelt@uksh.de0431-500-69614

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026